Meta-analyses of cognitive functions in early-treated adults with phenylketonuria

Neurosci Biobehav Rev. 2022 Dec:143:104925. doi: 10.1016/j.neubiorev.2022.104925. Epub 2022 Oct 22.

Abstract

Our study estimated size of impairment for different cognitive functions in early-treated adults with PKU (AwPKU) by combining literature results in a meta-analytic way. We analysed a large set of functions (N = 19), each probed by different measures (average = 12). Data were extracted from 26 PKU groups and matched controls, with 757 AwPKU contributing 220 measures. Effect sizes (ESs) were computed using Glass' ∆ where differences in performance between clinical/PKU and control groups are standardized using the mean and standard deviation of the control groups. Significance was assessed using measures nested within independent PKU groups as a random factor. The weighted Glass' ∆ was - 0.44 for all functions taken together, and - 0.60 for IQ, both highly significant. Separate, significant impairments were found for most functions, but with great variability (ESs from -1.02 to -0.18). The most severe impairments were in reasoning, visual-spatial attention speed, sustained attention, visuo-motor control, and flexibility. Effect sizes were larger with speed than accuracy measures, and with visuo-spatial than verbal stimuli. Results show a specific PKU profile that needs consideration when monitoring the disease.

Keywords: Executive functions, memory; Language; Metabolic diseases; PKU; Patterns of cognitive impairments; Speed and accuracy; Verbal vs visual.

Publication types

  • Meta-Analysis
  • Review

MeSH terms

  • Adult
  • Attention
  • Cognition*
  • Humans
  • Neuropsychological Tests
  • Phenylketonurias* / psychology
  • Problem Solving